Cargando…
Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510876/ https://www.ncbi.nlm.nih.gov/pubmed/26197053 http://dx.doi.org/10.1371/journal.pone.0134190 |
| _version_ | 1782382254460239872 |
|---|---|
| author | Sirgel, Frederick A. Warren, Robin M. Böttger, Erik C. Klopper, Marisa Victor, Thomas C. van Helden, Paul D. |
| author_facet | Sirgel, Frederick A. Warren, Robin M. Böttger, Erik C. Klopper, Marisa Victor, Thomas C. van Helden, Paul D. |
| author_sort | Sirgel, Frederick A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4510876 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-45108762015-07-24 Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks Sirgel, Frederick A. Warren, Robin M. Böttger, Erik C. Klopper, Marisa Victor, Thomas C. van Helden, Paul D. PLoS One Correction Public Library of Science 2015-07-21 /pmc/articles/PMC4510876/ /pubmed/26197053 http://dx.doi.org/10.1371/journal.pone.0134190 Text en © 2015 Sirgel et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
| spellingShingle | Correction Sirgel, Frederick A. Warren, Robin M. Böttger, Erik C. Klopper, Marisa Victor, Thomas C. van Helden, Paul D. Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks |
| title | Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks |
| title_full | Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks |
| title_fullStr | Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks |
| title_full_unstemmed | Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks |
| title_short | Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks |
| title_sort | correction: the rationale for using rifabutin in the treatment of mdr and xdr tuberculosis outbreaks |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510876/ https://www.ncbi.nlm.nih.gov/pubmed/26197053 http://dx.doi.org/10.1371/journal.pone.0134190 |
| work_keys_str_mv | AT sirgelfredericka correctiontherationaleforusingrifabutininthetreatmentofmdrandxdrtuberculosisoutbreaks AT warrenrobinm correctiontherationaleforusingrifabutininthetreatmentofmdrandxdrtuberculosisoutbreaks AT bottgererikc correctiontherationaleforusingrifabutininthetreatmentofmdrandxdrtuberculosisoutbreaks AT kloppermarisa correctiontherationaleforusingrifabutininthetreatmentofmdrandxdrtuberculosisoutbreaks AT victorthomasc correctiontherationaleforusingrifabutininthetreatmentofmdrandxdrtuberculosisoutbreaks AT vanheldenpauld correctiontherationaleforusingrifabutininthetreatmentofmdrandxdrtuberculosisoutbreaks |